These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37762140)

  • 41. Neuropsychological decrements in midlife type-2 diabetes are not associated with peripheral NLRP3 inflammasome responsiveness.
    Dyer AH; Batten I; Reddy C; Townsend L; Woods CP; O'Neill D; Gibney J; Kennelly SP; Bourke NM
    Front Immunol; 2022; 13():1021351. PubMed ID: 36311713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic HIV Infection Increases Monocyte NLRP3 Inflammasome-Dependent IL-1α and IL-1β Release.
    Hoel H; Dahl TB; Yang K; Skeie LG; Michelsen AE; Ueland T; Damås JK; Dyrhol-Riise AM; Fevang B; Yndestad A; Aukrust P; Trøseid M; Sandanger Ø
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The impact of human umbilical cord-derived mesenchymal stem cells on the pancreatic function of type 2 diabetic mice and their regulatory role on NLRP3 inflammasomes].
    Wang J; Yin YQ; Cheng Y; Li B; Su WL; Yu SY; Xue J; Gu YL; Zhang HX; Zhang LX; Zang L; Mu YM
    Zhonghua Nei Ke Za Zhi; 2023 Sep; 62(9):1077-1084. PubMed ID: 37650181
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of tai chi intervention on NLRP3 and its related antiviral inflammatory factors in the serum of patients with pre-diabetes.
    Hu S; Hu Y; Long P; Li P; Chen P; Wang X
    Front Immunol; 2022; 13():1026509. PubMed ID: 36248820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart.
    Fender AC; Kleeschulte S; Stolte S; Leineweber K; Kamler M; Bode J; Li N; Dobrev D
    Basic Res Cardiol; 2020 Jan; 115(2):10. PubMed ID: 31912235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome.
    Zhang ZT; Du XM; Ma XJ; Zong Y; Chen JK; Yu CL; Liu YG; Chen YC; Zhao LJ; Lu GC
    J Neuroinflammation; 2016 Apr; 13(1):71. PubMed ID: 27048470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel function of NLRP3 independent of inflammasome as a key transcription factor of IL-33 in epithelial cells of atopic dermatitis.
    Zheng J; Yao L; Zhou Y; Gu X; Wang C; Bao K; Sun Y; Hong M
    Cell Death Dis; 2021 Sep; 12(10):871. PubMed ID: 34561424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy.
    Higashimori A; Watanabe T; Nadatani Y; Takeda S; Otani K; Tanigawa T; Yamagami H; Shiba M; Tominaga K; Fujiwara Y; Arakawa T
    Mucosal Immunol; 2016 May; 9(3):659-68. PubMed ID: 26349656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Effects of Acute and Chronic Aerobic Activity on the Signaling Pathway of the Inflammasome NLRP3 Complex in Young Men.
    Khakroo Abkenar I; Rahmani-Nia F; Lombardi G
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30991661
    [No Abstract]   [Full Text] [Related]  

  • 50. Lipopolysaccharide/adenosine triphosphate induces IL‑1β and IL-18 secretion through the NLRP3 inflammasome in RAW264.7 murine macrophage cells.
    Xie Q; Shen WW; Zhong J; Huang C; Zhang L; Li J
    Int J Mol Med; 2014 Jul; 34(1):341-9. PubMed ID: 24789624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases.
    Abderrazak A; Syrovets T; Couchie D; El Hadri K; Friguet B; Simmet T; Rouis M
    Redox Biol; 2015; 4():296-307. PubMed ID: 25625584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibiting NLRP3 inflammasome activation prevents copper-induced neuropathology in a murine model of Wilson's disease.
    Dong J; Wang X; Xu C; Gao M; Wang S; Zhang J; Tong H; Wang L; Han Y; Cheng N; Han Y
    Cell Death Dis; 2021 Jan; 12(1):87. PubMed ID: 33462188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicotinamide Riboside Ameliorates Hepatic Metaflammation by Modulating NLRP3 Inflammasome in a Rodent Model of Type 2 Diabetes.
    Lee HJ; Hong YS; Jun W; Yang SJ
    J Med Food; 2015 Nov; 18(11):1207-13. PubMed ID: 25974041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing the expression of MiR-223-NLRP3-IL-1β axis and serum IL-1β levels in patients with severe COVID-19 and healthy individuals.
    Houshmandfar S; Khodadadi A; Mahmoudian-Sani MR; Nashibi R; Rashno M
    Immunobiology; 2023 Sep; 228(5):152710. PubMed ID: 37478686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Caspase-1 mediated interleukin-18 activation in neutrophils promotes the activity of rheumatoid arthritis in a NLRP3 inflammasome independent manner.
    Yang Z; Cao J; Yu C; Yang Q; Zhang Y; Han L
    Joint Bone Spine; 2016 May; 83(3):282-9. PubMed ID: 26775759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-36 receptor antagonist attenuates atherosclerosis development by inhibiting NLRP3 inflammasome.
    Tian Y; Ling XY; Chen DL; Zhang XQ; Qiu CM
    J Cell Physiol; 2020 Dec; 235(12):9992-9996. PubMed ID: 32488871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation.
    Chivero ET; Guo ML; Periyasamy P; Liao K; Callen SE; Buch S
    J Neurosci; 2017 Mar; 37(13):3599-3609. PubMed ID: 28270571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.
    Lee HM; Kim JJ; Kim HJ; Shong M; Ku BJ; Jo EK
    Diabetes; 2013 Jan; 62(1):194-204. PubMed ID: 23086037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of Inhibitory Capacities of 6-, 8- and 10-Gingerols/Shogaols on the Canonical NLRP3 Inflammasome-Mediated IL-1β Secretion.
    Ho SC; Chang YH
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29466287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death.
    Matsuoka T; Yoshimatsu G; Sakata N; Kawakami R; Tanaka T; Yamada T; Yoshida Y; Hasegawa S; Kodama S
    Sci Rep; 2020 Oct; 10(1):17920. PubMed ID: 33087823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.